Skip to main content

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) Stock Forecast 2025 - AI Price Prediction & Analysis


PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) AI Stock Price Forecast & Investment Analysis

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Stock Price Chart and Technical Analysis

Loading PACIFIC BIOSCIENCES OF CALIFORNIA, INC. interactive price chart and technical analysis...

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) - Comprehensive Stock Analysis & Investment Research

Deep dive into PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about PACIFIC BIOSCIENCES OF CALIFORNIA, INC., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: PACIFIC BIOSCIENCES OF CALIFORNIA, INC. operates in the Industrial Applications and Services sector, making it an emerging small-cap investment.

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (Stock Symbol: PACB) is a leading company in the Industrial Applications and Services sector , specifically operating within the Laboratory Analytical Instruments industry.

The organization employs approximately 699 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: With $156M in annual revenue and -1581.1% net margin, the company demonstrates developing profitability.

Annual Revenue: $156 million generating a -1581.1% net profit margin .

Market Capitalization: $493 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -34.5% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: Market positioning analysis based on available financial and operational metrics.

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. strategically competes in the highly dynamic Laboratory Analytical Instruments marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 147.6% gross margin, indicating strong pricing power and operational efficiency.

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. stock analysis.

Loading PACIFIC BIOSCIENCES OF CALIFORNIA, INC. comprehensive fundamental analysis and insider trading data...

Deep dive into PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if PACIFIC BIOSCIENCES OF CALIFORNIA, INC. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: With a P/E ratio of -1.52, the market sees the stock as potentially undervalued.

P/E Ratio -1.52x
P/B Ratio 8.01x
Market Cap $493M
EPS $-1.77
Book Value/Share $0.20
Revenue/Share $0.52
FCF/Share $0.09
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently PACIFIC BIOSCIENCES OF CALIFORNIA, INC. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: An ROE of -34.5% indicates room for improvement in shareholder value creation.

ROE -34.5%
ROA -11.0%
ROIC -11.1%
Gross Margin 147.6%
Operating Margin -1639.6%
Net Margin -1581.1%
EBT Margin -199.7%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: A current ratio of 16.87 indicates strong liquidity.

Current Ratio 16.87x
Quick Ratio 16.24x
D/E Ratio 1.28x
Financial Leverage 2.64x
Interest Coverage -17.7x
Working Capital $317M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: Free cash flow of $-176M indicates cash challenges that need attention.

Operating Cash Flow $-167M
Free Cash Flow $-176M
Capital Spending $-9M
FCF/Sales -130.9%
CapEx/Sales 6.8%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively PACIFIC BIOSCIENCES OF CALIFORNIA, INC. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: An asset turnover of 0.08x suggests room for improvement in asset utilization.

Asset Turnover 0.08x
Receivables Turnover 6.6x
Inventory Turnover 3.3x
Fixed Assets Turnover 2.0x
Days Sales Outstanding 55 days
Days Inventory 112 days
Payables Period 52 days
Cash Conversion Cycle 116 days
Understanding Financial Statement Data

What these metrics mean: Key figures from PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: With annual revenue of $156M, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $156M
R&D Expense $152M
SG&A Expense $102M
Cost of Goods Sold $20M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 53%
Cash & Short-term Investments 50%
Total Liabilities 62%
Short-term Debt 11%
Accounts Receivable 1%
Inventory 2%
Dividend & Shareholder Information
Shares Outstanding 300M
Growth Metrics (YoY)
EPS Growth -89.0%

Latest PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) stock price and investment outlook.

, source: Barron's

About Pacific Biosciences of California Inc. Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It ...

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
A Unlock Forecast - 30 Days FREE Trial $39604M 32.5x 6.2x
ASTC Unlock Forecast - 30 Days FREE Trial $7M 28.9x 0.3x
AVTR Unlock Forecast - 30 Days FREE Trial $9931M 14.5x 1.6x
BIO Unlock Forecast - 30 Days FREE Trial $8619M 27.0x 1.2x
BIO-B Unlock Forecast - 30 Days FREE Trial $7860M 24.6x 1.1x
BNGO Unlock Forecast - 30 Days FREE Trial $7M 0.0x 0.2x
BRKR Unlock Forecast - 30 Days FREE Trial $5796M 72.8x 3.3x
CTKB Unlock Forecast - 30 Days FREE Trial $502M 82.0x 1.3x
EYPT Unlock Forecast - 30 Days FREE Trial $792M -4.4x 3.2x
HBIO Unlock Forecast - 30 Days FREE Trial $17M -8.3x 1.1x
ILMN Unlock Forecast - 30 Days FREE Trial $15154M 12.1x 6.7x
LAB Unlock Forecast - 30 Days FREE Trial $485M -2.4x 1.1x
LCTC Unlock Forecast - 30 Days FREE Trial $9M x 1.5x
NAUT Unlock Forecast - 30 Days FREE Trial $123M -3.8x 0.7x
PACB Unlock Forecast - 30 Days FREE Trial $493M -1.5x 8.0x
PRPO Unlock Forecast - 30 Days FREE Trial $26M -1.2x 1.8x
RPID Unlock Forecast - 30 Days FREE Trial $137M -0.9x 2.5x
RVTY Unlock Forecast - 30 Days FREE Trial $10935M 38.3x 1.5x
SEER Unlock Forecast - 30 Days FREE Trial $137M -2.0x 0.4x
TXG Unlock Forecast - 30 Days FREE Trial $1538M -8.6x 2.0x
WAT Unlock Forecast - 30 Days FREE Trial $19929M 30.1x 9.2x

Frequently Asked Questions - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Stock Forecast

How accurate are PACIFIC BIOSCIENCES OF CALIFORNIA, INC. stock predictions?

Our AI model demonstrates 71% historical accuracy for PACB predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence PACIFIC BIOSCIENCES OF CALIFORNIA, INC. stock price forecasts?

Our analysis considers PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is PACIFIC BIOSCIENCES OF CALIFORNIA, INC. a good investment in 2025?

Based on our AI analysis, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are PACIFIC BIOSCIENCES OF CALIFORNIA, INC. forecasts updated?

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...